Get Premium to unlock powerful stock data

Calamos Growth and Income Portfolio Buys AbbVie Inc, Sells Fortive Corp, Vertex Pharmaceuticals Inc, Thermo Fisher Scientific Inc

Author's Avatar
insider
Sep 18, 2021
Article's Main Image
Investment company Calamos Growth and Income Portfolio (Current Portfolio) buys AbbVie Inc, sells Fortive Corp, Vertex Pharmaceuticals Inc, Thermo Fisher Scientific Inc during the 3-months ended 2021Q2, according to the most recent filings of the investment company, Calamos Growth and Income Portfolio. As of 2021Q2, Calamos Growth and Income Portfolio owns 106 stocks with a total value of $26 million. These are the details of the buys and sells.

For the details of Calamos Growth and Income Portfolio's stock buys and sells, go to https://www.gurufocus.com/guru/calamos+growth+and+income+portfolio/current-portfolio/portfolio

These are the top 5 holdings of Calamos Growth and Income Portfolio
  1. Apple Inc (AAPL) - 12,920 shares, 6.65% of the total portfolio. Shares reduced by 1.03%
  2. Microsoft Corp (MSFT) - 6,390 shares, 6.51% of the total portfolio. Shares reduced by 1.08%
  3. Amazon.com Inc (AMZN) - 370 shares, 4.78% of the total portfolio.
  4. Alphabet Inc (GOOGL) - 515 shares, 4.73% of the total portfolio.
  5. Facebook Inc (FB) - 2,015 shares, 2.63% of the total portfolio.
New Purchase: AbbVie Inc (ABBV)

Calamos Growth and Income Portfolio initiated holding in AbbVie Inc. The purchase prices were between $105.21 and $117.21, with an estimated average price of $112.5. The stock is now traded at around $107.730000. The impact to a portfolio due to this purchase was 0.57%. The holding were 1,345 shares as of 2021-06-30.

Sold Out: Fortive Corp (FTVPA.PFD)

Calamos Growth and Income Portfolio sold out a holding in Fortive Corp. The sale prices were between $977.88 and $1013.65, with an estimated average price of $996.99.

Sold Out: Vertex Pharmaceuticals Inc (VRTX)

Calamos Growth and Income Portfolio sold out a holding in Vertex Pharmaceuticals Inc. The sale prices were between $187.49 and $221.1, with an estimated average price of $209.31.

Reduced: Thermo Fisher Scientific Inc (TMO)

Calamos Growth and Income Portfolio reduced to a holding in Thermo Fisher Scientific Inc by 36.11%. The sale prices were between $441 and $508.24, with an estimated average price of $471.32. The stock is now traded at around $596.800000. The impact to a portfolio due to this sale was -0.24%. Calamos Growth and Income Portfolio still held 230 shares as of 2021-06-30.



Here is the complete portfolio of Calamos Growth and Income Portfolio. Also check out:

1. Calamos Growth and Income Portfolio's Undervalued Stocks
2. Calamos Growth and Income Portfolio's Top Growth Companies, and
3. Calamos Growth and Income Portfolio's High Yield stocks
4. Stocks that Calamos Growth and Income Portfolio keeps buying
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Rating:
NaN / 5 ( votes)

Please Login to leave a comment

Author's Avatar

insider